Search for Topics:
Title/Keyword
Journal
Submission Status
Category
 
 
Topics
Development of Diagnosis and Treatment Modalities in Obstetrics and Gynecology
Submit your Manuscript Submit your Abstract Propose a Topic

Topic Menu

► Topic Menu

Topic Editors

Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo 113-8655, Japan
Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago 683-8503, Japan
share announcement

Development of Diagnosis and Treatment Modalities in Obstetrics and Gynecology

Abstract submission deadline
20 January 2026
Manuscript submission deadline
20 March 2026
Viewed by
972

Topic Information

Dear Colleagues,

We are now accepting submissions for the topic “Development of Diagnosis and Treatment Modalities in Obstetrics and Gynecology”. This call invites original research, reviews, and clinical studies focusing on recent advances in hormonal and surgical treatments for uterine fibroids, endometriosis, and adenomyosis; the impact of these conditions on IVF-ET outcomes; and strategies to prevent pregnancy complications. We also invite submissions with a focus on the following topics: innovations in imaging for gynecologic disorders, management of dysmenorrhea across age groups, and the diverse aspects of reproductive endocrinological diseases. Furthermore, papers addressing the optimization of infertility treatments through various therapeutic approaches and the integration of new technologies in reproductive medicine and gynecologic oncology are also welcome. The submissions should contribute to improving diagnostic precision and individualized care in women’s health.

Dr. Osamu Hiraike
Dr. Fuminori Taniguchi
Topic Editors

Keywords

  • hormonal treatments for uterine fibroids, endometriosis, and adenomyosis
  • IVF-ET complicated by uterine fibroids, endometriosis, and adenomyosis
  • efficacy of surgical treatment in preventing pregnancy complications with uterine fibroids, endometriosis, and adenomyosis
  • imaging for the diagnosis of uterine fibroids, endometriosis, and adenomyosis
  • dysmenorrhea in adolescents and perimenopausal women
  • various aspects of reproductive endocrinological disease
  • optimization of infertility treatment using various modalities
  • new modalities in reproductive medicine and gynecologic oncology

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomedicines
biomedicines 		3.9 6.8 2013 17 Days CHF 2600 Submit
Diagnostics
diagnostics 		3.3 5.9 2011 21 Days CHF 2600 Submit
Endocrines
endocrines 		- 2.4 2020 41.7 Days CHF 1000 Submit
Journal of Clinical Medicine
jcm 		2.9 5.2 2012 17.7 Days CHF 2600 Submit
Journal of Personalized Medicine
jpm 		- 6.0 2011 21.5 Days CHF 2600 Submit
International Journal of Molecular Sciences
ijms 		4.9 9.0 2000 20.5 Days CHF 2900 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
13 pages, 793 KiB  
Article
Uterine Artery Embolization as an Alternative Therapeutic Option in Adenomyosis: An Observational Retrospective Single-Center Study
by Melinda-Ildiko Mitranovici, Dan Costachescu, Dan Dumitrascu-Biris, Liviu Moraru, Laura Georgiana Caravia, Florin Bobirca, Elena Bernad, Viviana Ivan, Adrian Apostol, Ioana Cristina Rotar and Lucian Marginean
J. Clin. Med. 2025, 14(11), 3788; https://doi.org/10.3390/jcm14113788 - 28 May 2025
Viewed by 676
Abstract
Adenomyosis is a benign gynecologic disease that mainly affects women aged 30–50 years old. Background: This pathology is characterized by glands and stroma of the endometrium that enter the myometrium and is confirmed through histopathological examination after hysterectomy. Transvaginal ultrasound is the [...] Read more.
Adenomyosis is a benign gynecologic disease that mainly affects women aged 30–50 years old. Background: This pathology is characterized by glands and stroma of the endometrium that enter the myometrium and is confirmed through histopathological examination after hysterectomy. Transvaginal ultrasound is the most accepted imaging approach for the diagnosis and classification of adenomyosis. Existing medical treatments are not curative and are associated with several side effects. Uterine artery embolization is an alternative treatment for controlling the symptoms of adenomyosis with less trauma while preserving the uterus. Methods: The aim of our study was to observe the utility of uterine artery embolization (UAE) compared to hysterectomy in specific cases of adenomyosis. A retrospective cohort study was carried out between February 2024 and April 2025. We included 52 patients in our study: 27 opted for hysterectomy, while the other 25 chose to receive uterine artery embolization between January 2017 and December 2018. Clinical follow-up was assessed using a questionnaire regarding symptomatic changes in menorrhagia, pelvic pain, and quality of life before and after the surgical procedure. Statistical analyses were performed. Results: Patients opted for hysterectomy in cases of severe abnormal uterine bleeding before surgery that severely affected quality of life (p < 0.03 and p < 0.001). After surgery, pelvic pain improved for women who underwent UAE, but patients also reported no pelvic pain after hysterectomy. Furthermore, mild to moderate abnormal uterine bleeding was reported in cases of UAE, and bleeding stopped completely for women who had their uterus removed (p < 0.001). Quality of life improved for both groups and was reported as being good after the interventions. Conclusions: Embolization remains an alternative therapeutic option in adenomyosis but not a substitute for hysterectomy. This was concluded based on a case-by-case evaluation, depending on the desire for pregnancy, with a focus on improved clinical outcomes. Full article
(This article belongs to the Topic Development of Diagnosis and Treatment Modalities in Obstetrics and Gynecology)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop